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Abstract: Multimorbidity increases with age and is generally more common in women, but little is
known about sex effects on the “typology” of multimorbidity. We have characterized multimorbidity
in a large nationally representative primary care dataset in terms of sex in ten year age groups from
25 years to 75 years and over, in a cross-sectional analysis of multimorbidity type (physical-only,
mental-only, mixed physical and mental; and commonest conditions) for 1,272,685 adults in Scotland.
Our results show that women had more multimorbidity overall in every age group, which was most
pronounced in the 45–54 years age group (women 26.5% vs. men 19.6%; difference 6.9 (95% CI 6.5 to
7.2). From the age of 45, physical-only multimorbidity was consistently more common in men, and
physical-mental multimorbidity more common in women. The biggest difference in physical-mental
multimorbidity was found in the 75 years and over group (women 30.9% vs. men 21.2%; difference
9.7 (95% CI 9.1 to 10.2). The commonest condition in women was depression until the age of 55 years,
thereafter hypertension. In men, drugs misuse had the highest prevalence in those aged 25–34 years,
depression for those aged 35–44 years, and hypertension for 45 years and over. Depression, pain,
irritable bowel syndrome and thyroid disorders were more common in women than men across all
age groups. We conclude that the higher overall prevalence of multimorbidity in women is mainly
due to more mixed physical and mental health problems. The marked difference between the sexes
over 75 years especially warrants further investigation.
Keywords: multimorbidity; sex; primary care
1. Introduction
Multimorbidity is usually defined as the co-occurrence of two or more long term conditions
within one individual, and is an increasing problem with a reported doubling of prevalence over the
last 20 years [1]. It is a global phenomenon and has now become the norm rather than exception in
many populations [2–5]. Multimorbidity is associated with increased mortality [6–8], lower quality
of life [9–11], and greater utilization of healthcare including unplanned admissions [12–14] and thus
higher healthcare costs [6,15–17]. Patients with multimorbidity are less satisfied with care provided [18],
perhaps due to the fragmentation of care resulting from the single disease-focus that drives much of
current health care [19–21].
The prevalence of multimorbidity rises rapidly with increasing age [4–6,16,22–24], although, the
absolute number of individuals with multimorbidity is often higher in those under 65 years [4,25,26]. It
is also strongly associated with socioeconomic deprivation and occurs 10–15 years earlier in individuals
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living in the most deprived compared with the least deprived areas [3–5]. The effect of sex on
multimorbidity has been less well defined [3]. Most previous studies have shown an increased
prevalence of multimorbidity among women [1,6,16,26], though not all studies find this [2,27,28].
Although in almost all countries in the world women have a longer life expectancy than men [29],
they are more often affected by a number of non-fatal chronic diseases that decrease quality of life and
everyday physical ability [23,30].
Multimorbidity is a broad concept, and can be characterised further in a number of ways, such
as physical-only, mental-only, and mixed mental and physical [24], as well as by the commonest
combinations of individual conditions. The typology of multimorbidity by sex has not been well
documented in large primary care populations. Therefore, this study aimed to examine the relationship
between sex and different types of multimorbidity across different age groups, using cross-sectional
data from a nationally representative large primary care dataset.
2. Methods
We obtained a dataset for 1,751,841 patients of all ages, who were alive on 31 March 2007 and
permanently registered with 314 Scottish general practices, from the Primary Care Clinical Informatics
Unit at the University of Aberdeen, UK [31]. This accounts for about a third of the Scottish population
and is representative of it in terms of age, sex, and socioeconomic deprivation. The NHS National
Research Ethics Service had previously approved the use of these anonymised data for research
purposes and this analysis did not require independent review [4].
Forty conditions in total were analysed as previously defined [4] using either Quality and
Outcomes Framework (QOF) register Read Code sets where available (Read Codes are the clinical
coding system used in UK general practice) [32], other Read Code sets used by NHS Scotland for
non-QOF conditions, or combinations of Read Codes and prescription data where coding was known
to be likely to under-record important conditions. The appendix provides further detail of definitions
and the 40 conditions analysed.
Multimorbidity was defined as the presence of two or more disorders in an individual. The choice
of conditions was based on recommendations from systematic review for multimorbidity measure [33]
as well as diseases in QOF within UK General Practice (GP) contract and important diseases identified
by NHS Scotland [32,34]. To specifically examine multimorbidity in terms of physical and mental
health disorders, we defined each condition as either a physical or mental health disorder. Of the
40 conditions we classified 32 as physical and 8 as mental disorders (depression, anxiety, drugs misuse,
alcohol misuse, schizophrenia/bipolar, dementia, learning disability and anorexia).
In order to characterize the prevalence and type of multimorbidity, we additionally analysed how
many people had: (a) 2 or more physical conditions but no mental health conditions (physical-only);
(b) 2 or more mental health conditions but no physical conditions (mental-only); or (c) 2 or more
conditions including at least 1 physical and 1 mental (mixed physical and mental). We then examined
the top 10 most common conditions in those with multimorbidity separately in each age group by sex.
As the current analysis focused on adults with multimorbidity, we excluded adults aged under
25 years in whom multimorbidity is uncommon (prevalence 1.9%) [4]. We divided the remaining
patients into 6 age groups (25–34, 35–44, 45–54, 55–64, 65–74 and 75 and over) to reflect different
stages in the life course. For each of these age groups, we calculated the number (and percentage) of
patients with: no conditions; with one condition; and with two or more conditions. We used graphical
display to compare differences by age group in patterns of multimorbidity by sex. We calculated the
ten most prevalent conditions by age group and separately for men and women with two or more
conditions by dividing the number of patients with each condition by the number of patients in the
relevant age groups with two or more conditions. All analysis was conducted using Stata version 13.0
(Stata, College Station, TX, USA).
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3. Results
The analysis involved 1,272,685 adults aged 25 years and over, of whom 51% were women and 49%
were men. Table 1 shows differences in prevalence of morbidity by age group and sex. For both men
and women, the number and percentage of people with multimorbidity was higher in each successive
ten-year age group within each sex, however, there were more people with multimorbidity in absolute
numbers under the age of 65 (201,311 vs. 194,996). There were more women with multimorbidity
than with a single condition or no condition in all age groups above the age of 55, whereas this was
only true in men above the age of 65. The prevalence of multimorbidity (two or more conditions) was
higher in women than in men in every age group, although the differences were small over the age
of 65. The biggest sex difference was found in the 45–54 age group (women 26.5% vs. men 19.6%;
difference 6.9 (95% CI 6.5 to 7.2).
Table 2 shows the prevalence of different types of multimorbidity (physical or mental or mixed)
across age groups by sex. In general, the differences in prevalence of all types of multimorbidity
between men and women were markedly small. However, whilst physical-only morbidity increased
with age for both men and women, differences were small up to the age of 64 years but were marginally
higher for women. After the age of 65 more men than women had physical-only multimorbidity.
The most significant difference was observed in the over 75 age group (women 45.3% vs. men 53.5%;
difference ´8.3 (95% CI ´7.7 to ´8.7). Gender differences were greatest for mixed physical and mental
multimorbidity (as compared with mental-only and physical-only) at all ages but the magnitude of this
difference varied with age. Women’s higher prevalence of mixed physical and mental multimorbidity
was small in absolute terms at age 25–34 (2.1% (95% CI 1.9 to 2.2), increasing to around 5% between
the ages 45 and 74), and highest in those above the age of 75 (women 30.9% vs. men 21.2%; difference
9.7 (95% CI 9.1 to 10.2).
Figure 1 shows the number of people with the different types of multimorbidity by age group
and sex. It illustrates that, overall, women have more multimorbidity across the life course but
sex differences are small and diminish even more after 55–64 years. It shows that a large part of
this reduction in sex difference is due to a steeper rise in the prevalence of men with physical only
multimorbidity compared to women.
Table 3 shows prevalence (%) of the conditions which feature in the top 10 most commonly found
in men or women with multimorbidity within each age group. For women with multimorbidity below
the age of 55, depression was the condition with the highest prevalence, whereas above the age of 55
hypertension was the most common condition. In contrast for men with multimorbidity, drugs misuse
had the highest prevalence for men aged 25–34, depression for men aged 35–44, and hypertension
for men aged 45 and over. Women had a consistently higher prevalence of depression, pain, IBS
and thyroid disorders across all age groups. For men under 45 with multimorbidity, compared to
women in the same age group, prevalence was only notably higher for substance (alcohol and drugs)
misuse. Amongst people with multimorbidity, higher prevalence’s of coronary heart disease (CHD)
and diabetes were recorded in men than women from the ages of 45 and over.
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Table 1. Number of conditions by age group and sex.
Age Group No Conditions One Condition Two Conditions
Women No. (%) Men No. (%) Difference (95% CI) Women No. (%) Men No. (%) Difference (95% CI) Women No. (%) Men No. (%) Difference (95% CI)
25–34 78,941 (70.1) 90,806 (77.7) ´7.6 (´7.2 to ´7.9) 22,701 (20.2) 18,261 (15.6) 4.6 (4.2 to 4.9) 10,911 (9.7) 7776 (6.7) 3.0 (2.8 to 3.2)
35–44 80,309 (58.9) 99,029 (69.4) ´10.5 (´10.1 to ´10.8) 32,966 (24.1) 27,805 (19.5) 4.6 (4.3 to 5.0) 23,025 (16.9) 15,859 (11.1) 5.8 (5.5 to 6.0)
45–54 59,328 (47.3) 72,592 (56.4) ´9.1 (´8.7 to ´9.5) 32,751 (26.1) 30,702 (23.9) 2.2 (1.9 to 2.5) 33,230 (26.5) 25,191 (19.6) 6.9 (6.5 to 7.2)
55–64 35,128 (31.9) 40,715 (37.2) ´5.3 (´4.8 to ´5.7) 29,120 (26.4) 29,051 (26.6) ´0.2 (0.2 to ´0.4) 45,737 (41.6) 39,582 (36.2) 5.4 (4.9 to 5.7)
65–74 14,868 (18.0) 13,794 (18.9) ´0.9 (´0.5 to ´1.2) 18,567 (22.5) 16,501 (22.7) ´0.2 (0.2 to ´0.5) 49,009 (59.4) 42,541 (58.0) 1.4 (0.5 to 1.5)
75 plus 6989 (8.3) 4864 (9.4) ´1.1 (´0.7 to ´1.3) 12,532 (14.9) 8058 (15.5) ´0.6 (´0.1 to ´1.0) 64,491 (76.7) 38,955 (75.1) 1.6 (1.2 to 2.1)
Analysis based on 40 chronic conditions; 32 physical and 8 mental, percentages in the conditions columns relate distribution within each separate age group by sex.
Table 2. Differences in type of multimorbidity by age group and sex.
Age Group Physical only Multimorbidity Mental only Multimorbidity Mixed Physical and Mental Multimorbidity
Women No. (%) Men No. (%) Difference (95% CI) Women No. (%) Men No. (%) Difference (95% CI) Women No. (%) Men No. (%) Difference (95% CI)
25–34 3185 (2.8) 1925 (1.6) 1.2 (1.0 to 1.3) 1847 (1.6) 2172 (1.8) ´0.2 (´0.1 to ´0.3) 5879 (5.2) 3679 (3.1) 2.1 (1.9 to 2.2)
35–44 7785 (5.7) 5455 (3.8) 1.9 (1.7 to 3.0) 2367 (1.7) 2620 (1.8) ´0.1 (´0.0 to ´0.2) 12,873 (9.4) 7784 (5.5) 3.9 (3.7 to 4.1)
45–54 13,999 (11.1) 12,643 (9.8) 1.3 (1.1 to 1.5) 1659 (1.3) 1479 (1.1) 0.2 (0.0 to 0.3) 17,572 (14.0) 11,069 (8.6) 5.4 (5.1 to 5.7)
55–64 25,175 (22.9) 24,596 (22.5) 0.4 (0.0 to 0.7) 891 (0.08) 735 (0.07) 0.01 (0.00 to 0.06) 19,671 (17.9) 14,251 (13.0) 4.9 (4.5 to 5.1)
65–74 31,711 (38.5) 30,825 (42.3) ´3.8 (´3.3 to ´4.3) 420 (0.05) 245 (0.03) 0.02 (0.01 to 0.03) 16,878 (20.5) 11,471 (15.7) 4.8 (4.3 to 5.1)
75 plus 38,088 (45.3) 27,824 (53.5) ´8.3 (´7.7 to ´8.7) 459 (0.05) 127 (0.02) 0.03 (0.02 to 0.04) 25,944 (30.9) 11,004 (21.2) 9.7 (9.1 to 10.2)
Analysis based on 40 chronic conditions; 32 physical and 8 mental. Percentages are the % in each age group by sex.
Int. J. Environ. Res. Public Health 2016, 13, 391 5 of 12
Table 3. Differences by age and sex in the top 10 most prevalent conditions for multimorbid patients.
Rank Order of
Conditions
Age 25–34 (Women)
% (95% CI)
n = 10,911
Age 25–34 (Men)
% (95% CI)
n = 7776
Age 35–44 (Women)
% (95% CI)
n = 23,025
Age 35–44 (Men)
% (95% CI)
n = 15,859
Age 45–54 (Women)
% (95% CI)
n = 33,230
Age 45–54 (Men)
% (95% CI)
n = 25,191
1 Depression52.9 (51.9–53.8)
Drugs Misuse
38.5 (37.4–39.6)
Depression
53.7 (53.1–54.3)
Depression
36.9 (36.1–37.7)
Depression
46.5 (46.0–47.0)
Hypertension
36.0 (35.4–36.6)
2 Asthma27.6 (26.8–28.4)
Depression
36.4 (35.3–37.4)
Pain
28.4 (27.8–29.0)
Pain
23.5 (22.8–24.1)
Pain
32.0 (31.5–32.5)
Depression
28.5 (27.9–28.0)
3 Pain21.4 (20.6–22.1)
Alcohol dependence
22.8 (21.8–23.7)
Asthma
22.6 (22.0–23.1)
Drugs Misuse
22.4 (21.8–23.1)
Hypertension
27.0 (26.5–27.5)
Pain
26.4 (25.9–26.9)
4 IBS19.9 (19.1–20.6)
Asthma
22.1 (21.1–23.0)
IBS
20.2 (19.7–20.7)
Alcohol dependence
21.8 (21.2–22.4)
Thyroid
19.5 (19.1–19.9)
Alcohol dependence
19.0 (18.5–19.5)
5 Anxiety19.5 (18.7–20.2)
Anxiety
20.4 (19.5–21.3)
Anxiety
18.2 (17.7–18.7)
Asthma
19.2 (18.6–19.8)
Asthma
18.7 (18.3–19.1)
Dyspepsia
18.9 (18.4–19.4)
6 Drugs Misuse16.9 (16.1–17.6)
Pain
16.0 (15.1–16.7)
Thyroid
15.7 (15.2–16.1)
Dyspepsia
19.1 (18.4–19.7)
Dyspepsia
18.1 (17.7–18.5)
Diabetes
17.8 (17.3–18.3)
7 Thyroid11.0 (10.3–11.5)
Dyspepsia
12.4 (11.6–13.1)
Dyspepsia
14.6 (14.1–15.1)
Anxiety
17.2 (16.6–19.8)
IBS
17.8 (17.4–18.2)
Asthma
14.4 (14.0–14.8)
8 Dyspepsia9.0 (8.5–9.5)
Schizophren/Bi-polar
8.8 (8.1–9.4)
Hypertension
11.6 (11.2–12.0)
Hypertension
16.6 (16.0–17.2)
Anxiety
15.5 (15.0–15.8)
Inflammatory
arthritis
12.6 (12.2–13.0)
9 Alcohol dependence8.6 (8.1–9.1)
Hearing loss
7.9 (7.3–8.5)
Drugs Misuse
9.5 (9.1–9.8)
Diabetes
10.5 (10.0–11.0)
Diabetes
10.7 (10.4–11.0)
Anxiety
11.2 (10.8–11.6)
10 Hearing loss6.2 (3.2–4.0)
IBS
6.7 (6.1–7.3)
Alcohol dependence
7.4 (7.1–7.7)
IBS
8.0 (7.6–8.4)
Inflammatory arthritis
9.5 (9.2–9.8)
CHD
10.9 (10.5–11.3)
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Table 3. Cont.
Rank order of
conditions
Age 55–64 (Women)
% (95% CI)
n = 47,727
Age 55–64 (Men)
% (95% CI)
n = 39,852
Age 65–74 (Women)
% (95% CI)
n = 49,009
Age 65–74 (Men)
% (95% CI)
n = 42,541
Age 75&over (Women)
% (95% CI)
n = 64,491
Age 75& over (Men)
% (CI 95%)
n = 38,955
1 Hypertension46.6 (46.1–47.0)
Hypertension
50.8 (50.3–51.2)
Hypertension
59.3 (58.8–59.7)
Hypertension
57.1 (56.7–57.6)
Hypertension
64.4 (64.0–64.7)
Hypertension
57.9 (57.3–58.4)
2 Depression34.7 (34.2–35.1)
Pain
27.8 (27.4–28.2)
Pain
33.5 (33.0–33.9)
CHD
33.2 (32.8–33.7)
CHD
26.6 (26.3–26.9)
CHD
38.8 (38.2–39.2)
3 Pain34.5 (34.0–34.9)
CHD
22.2 (21.8–22.6)
Depression
23.5 (23.2–23.9)
Pain
25.9 (25.5–26.4)
Pain
26.3 (26.0–26.6)
Diabetes
19.9 (19.5–20.3)
4 Thyroid21.8 (21.4–22.2)
Diabetes
21.8 (21.3–22.3)
Thyroid
22.4 (22.1–22.8)
Diabetes
24.1 (23.7–24.5)
Thyroid
21.5 (21.2–21.8)
Stroke-TIA
19.2 (18.8–19.5)
5 Dyspepsia18.5 (18.1–18.8)
Depression
20.3 (19.9–20.7)
CHD
19.9 (19.6 –20.3)
COPD
15.1 (14.8–15.4)
Depression
20.7 (20.4–21.0)
Pain
19.1 (18.7–19.5)
6 Asthma14.7 (14.3–15.0)
Dyspepsia
15.6 (15.2–16.0)
Diabetes
18.4 (18.1–18.8)
Inflammatory
arthritis
14.1 (13.8–14.5)
Chronic Kidney Disease
19.4 (19.1–19.7)
Hearing Loss
18.0 (17.6–18.4)
7 Diabetes14.2 (13.9–14.5)
Alcohol dependence
14.6 (14.3–14.9)
Dyspepsia
18.0 (17.7–18.4)
Dyspepsia
13.5 (13.1–13.8)
Constipation
18.0 (17.7–18.3)
Chronic Kidney
Disease
16.8 (16.5–17.1)
8
Irritable bowel
syndrome
13.3 (13.0–13.6)
Inflammatory
arthritis
14.3 (14.0–14.6)
COPD
14.2 (13.9–14.5)
Stroke-TIA
12.9 (12.6–13.2)
Dyspepsia
16.4 (16.1–16.7)
COPD
16.6 (16.2–16.9)
9 Anxiety13.1 (12.8–13.4)
COPD
10.7 (10.4–11.0)
Inflammatory
arthritis
13.4 (13.0–13.84)
Depression
12.7 (12.4–13.0)
Anxiety
15.9 (15.6–16.1)
Any Cancer
15.5 (15.1–15.8)
10
Inflammatory
poly-arthropathy
12.5 (12.2–12.8)
Asthma
10.2 (9.9–10.5)
Anxiety
13.1 (12.8–13.4)
Hearing Loss
12.2 (11.8–12.5)
Diabetes
15.5 (15.2–15.8)
Constipation
15.2 (14.8–15.5)
Abbreviations: Coronary Heart Disease (CHD); Chronic obstructive pulmonary disease (COPD); Irritable bowel syndrome (IBS).
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75 years and over group. The commonest condition in women was depression until the age of 55 years,
thereafter hypertension. Depression, pain, irritable bowel syndrome and thyroid disorders were more
common in women than men across all age groups.
4.1. Relationship with Existing Literature
Several studies have reported that women have more multimorbidity than men [4,26,35], as
reflected in a recent systematic review [3]. The level of sex difference in multimorbidity varies between
studies. One study reported little difference between the sexes on the risk of being mutlimorbid [36].
This study used 20 chronic conditions and the difference in reported results may be explained by
the inclusion in our study of additional conditions which are far more prevalent in women such as
migraine and thyroid diseases. Moreover, most previous studies have had either much smaller samples
sizes [26,27,36,37] or were restricted to elderly [38–40] or hospitalised people [41], whereas the current
study examined a nationally representative one-third of the Scottish population.
As far as we are aware, our study is the first to show prevalence rates of different types
of multimorbidity and particular conditions by sex and across all ages in a large, nationally
representative dataset.
In terms of mental health morbidity, our results show that physical-mental multimorbidity is
much more common in women than men. Depression was more prevalent in women than men and
was the most frequently occurring condition among women below the age of 55. These findings
agree with previously published studies in both multimorbid [4,42] and single disease analyses. [43]
Whether this reflects “true” levels of depression in patients with at least one other condition, or a
difference in the presentation (by patients) or recognition (by patients and doctors) of depression in
people with other long-term conditions cannot be determined from these data. Experimental studies
support differential recognition by doctors of potential symptoms in women and men [44–46], at least
for cardiovascular disease and depression. In addition, below the ages of around 60 years, women
are more likely to have contact with their general practitioner [47], and there thus may be differences
between men and women of prior recording of depression which may alert GPs to be more alert to
depression when they see female patients with physical conditions. Recent survey data have shown
that 90% of women with depression discussed it with their doctor [48]. Underestimation of depression
in men could perhaps also be explained by so called “masculine” ways of responding to negative affect,
less help seeking and lack of consideration for some of such symptoms in commonly used diagnostic
tools for depression [49]. This may be important particularly in older populations as previous literature
has described that depression is related to negative outcomes within chronic diseases such as, e.g.,
coronary heart disease [50].
We also found higher rates of alcohol misuse for men with multimorbidity, particularly in the
younger age groups, which have also been reported elsewhere [51,52]. This is perhaps not surprising
given the consistent finding of higher consumption of alcohol in general population samples of men
compared with women in many cultures [53]. It is also consistent with the view that men’s mental
distress and depressive illness may disproportionately present as substance abuse [54,55].
Although we did not examine the utilization of healthcare in the current study, increased
multimorbidity among female patients, especially those with mental health problems, could
explain the previous results in literature in relation to consultation rates and emergency inpatient
admissions [12,47]. A recent study using a large dataset in England reported that consultation rate
among women was higher than men, which was only partially explained by reproduction related
visits [47].
4.2. Strengths and Limitations
As far as we are aware, the present study represents the most comprehensive study to date on
sex associations with multimorbidity, based as it is on a large nationally representative primary care
sample. The study has, however, several limitations. Firstly, it was based on electronic medical records
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from GP practices and thus relies on the diligence of the practitioners in coding conditions, and their
propensity to do this equally diligently by sex for all conditions. We used mixtures of morbidity codes
and prescribing to define and measure some conditions, firstly to ensure that coded conditions were
still “active” (e.g., asthma code plus recent inhaler prescription) and secondly because some conditions
not incentivised in the UK GPs Quality and Outcomes Framework (such as osteoarthritis) are poorly
recorded. In addition, the physical conditions we used did not include chronic conditions that are
specific to women (in order to compare men and women across conditions). The study is also not able
to take account of severity of any of the conditions as these data were not available. Additionally, we
did not examine ethnic differences in multimorbidity.
4.3. Implications for Policy and Practice
This study shows that multimorbidity differs between men and women in terms of types of
conditions as well as prevalence, raising the potential need for a more tailored gendered approach to
patients with multiple chronic conditions.
Lack of appropriate guidelines and integrated health systems creates a gap between patients’
healthcare needs and experiences and its provision [55]. As reflected in previous studies, this
gap could be decreased by improved integration and a generalist patient-centred approach [56].
Given the apparently large additional multimorbidity burden in women relating to sex-specific
conditions, Gender sensitive services development may be important in some settings, including the
implementation of sex related health and socio-economic risk factors reduction policies as suggested
by WHO [57,58]
Further research is required to understand the differing burdens and impacts of multimorbidity
typologies in men and women.
5. Conclusions
Our study has shown that, overall, women have more multimorbidity across all age groups,
which is driven by a higher prevalence of combined physical and mental multimorbidity in women
than men, with the biggest difference in this category being found among the oldest (above the age of
75 year). This warrants further study, including the severity, burden and effects of such sex differences
in multimorbidity.
Acknowledgments: This work was funded by the Chief Scientist Office of Scottish Government Health Directorate
(Applied Research Programme Grant ARPG/07/1), but study design, data analysis, interpretation and publication
were the responsibility of the research team who had sole access to the data. The data contained herein were
provided by the Primary Care Clinical Informatics Unit (PCCIU) at the University of Aberdeen. The views in
this publication are not necessarily the views of the University of Aberdeen, its agents, or employees. Particular
thanks go to Katie Wilde and Fiona Chaloner, University of Aberdeen who carried out the initial data extraction
and management. Kate Hunt is funded by the Medical Research Council (MC_UU_12017/12).
Author Contributions: Stewart W. Mercer and Bruce Guthrie conceived and designed the original study, and
Karolina Agur with input from all the other authors including Kate Hunt conceived and designed this secondary
analysis; Gary McLean analysed the data. Karolina Agur wrote the first draft of the paper, and all authors
contributed to revisions and the final version.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Uijen, A.A.; van de Lisdonk, E.H. Multimorbidity in primary care: Prevalence and trend over the last
20 years. Eur. J. Gen. Pract. 2008, 14 (Suppl. 1), 28–32. [CrossRef] [PubMed]
2. Fortin, M.; Bravo, G.; Hudon, C.; Vanasse, A.; Lapointe, L. Prevalence of multimorbidity among adults seen
in family practice. Ann. Fam. Med. 2005, 3, 223–228. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2016, 13, 391 10 of 12
3. Violan, C.; Foguet-Boreu, Q.; Flores-Mateo, G.; Salisbury, C.; Blom, J.; Freitag, M.; Glynn, L.; Muth, C.;
Valderas, J.M. Prevalence, determinants and patterns of multimorbidity in primary care: A systematic review
of observational studies. PLoS ONE 2014, 9, e102149.
4. Barnett, K.; Mercer, S.W.; Norbury, M.; Watt, G.; Wyke, S.; Guthrie, B. Epidemiology of multimorbidity and
implications for health care, research, and medical education: A cross-sectional study. Lancet 2012, 380, 37–43.
[CrossRef]
5. Afshar, S.; Roderick, P.J.; Kowal, P.; Dimitrov, B.D.; Hill, A.G. Multimorbidity and the inequalities of global
ageing: A cross-sectional study of 28 countries using the World Health Surveys. BMC Public Health 2015, 15,
776. [CrossRef] [PubMed]
6. Marengoni, A.; Angleman, S.; Melis, R.; Mangialasche, F.; Karp, A.; Garmen, A.; Meinow, B.; Fratiglioni, L.
Aging with multimorbidity: A systematic review of the literature. Ageing Res. Rev. 2011, 10, 430–439.
[CrossRef] [PubMed]
7. Byles, J.E.; Catherine, D.; Lynne, P.; Rachel, O.; Carla, T. Single index of multimorbidity did not predict
multiple outcomes. J. Clin. Epidemiol. 2005, 58, 997–1005. [CrossRef] [PubMed]
8. Tooth, L.; Hockey, R.; Byles, J.; Dobson, A. Weighted multimorbidity indexes predicted mortality, health
service use, and health-related quality of life in older women. J. Clin. Epidemiol. 2008, 61, 151–159. [CrossRef]
[PubMed]
9. Loza, E.; Jover, J.A.; Rodriguez, L.; Carmona, L.; EPISER study group. Multimorbidity: Prevalence, effect on
quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease.
Semin. Arthritis Rheum. 2009, 38, 312–319. [CrossRef] [PubMed]
10. Le Reste, J.Y.; Nabbe, P.; Manceau, B.; Lygidakis, C.; Doerr, C.; Lingner, H.; Czachowski, S.; Munoz, M.;
Argyriadou, S.; Claveria, A.; et al. The European General Practice Research Network presents a
comprehensive definition of multimorbidity in family medicine and long term care, following a systematic
review of relevant literature. J. Am. Med. Dir. Assoc. 2013, 14, 319–325. [CrossRef] [PubMed]
11. Agborsangaya, C.B.; Lau, D.; Lahtinen, M.; Cooke, T.; Johnson, J.A. Health-related quality of life and
healthcare utilization in multimorbidity: Results of a cross-sectional survey. Qual. Life Res. 2013, 22, 791–799.
[CrossRef] [PubMed]
12. Payne, R.A.; Abel, G.A.; Guthrie, B.; Mercer, S.W. The effect of physical multimorbidity, mental health
conditions and socioeconomic deprivation on unplanned admissions to hospital: A retrospective cohort
study. CMAJ 2013, 185, E221–E228. [CrossRef] [PubMed]
13. Schneider, K.M.; O’Donnell, B.E.; Dean, D. Prevalence of multiple chronic conditions in the United States’
medicare population. Health Qual. Life Outcomes 2009, 7, 82. [CrossRef] [PubMed]
14. Wolff, J.L.; Starfield, B.; Anderson, G. Prevalence, expenditures, and complications of multiple chronic
conditions in the elderly. Arch. Intern. Med. 2002, 162, 2269–2276. [CrossRef] [PubMed]
15. Brilleman, S.L.; Purdy, S.; Salisbury, C.; Windmeijer, F.; Gravelle, H.; Hollinghurst, S. Implications of
comorbidity for primary care costs in the UK: A retrospective observational study. Br. J. Gen. Pract. 2013, 63,
e274–e282. [CrossRef] [PubMed]
16. Salisbury, C.; Johnson, L.; Purdy, S.; Valderas, J.M.; Montgomery, A.A. Epidemiology and impact of
multimorbidity in primary care: A retrospective cohort study. Br. J. Gen. Pract. 2011, 61, e12–e21. [CrossRef]
[PubMed]
17. France, E.F.; Wyke, S.; Gunn, J.M.; Mair, F.S.; McLean, G.; Mercer, S.W. Multimorbidity in primary care: A
systematic review of prospective cohort studies. Br. J. Gen. Pract. 2012, 62, e297–e307. [CrossRef] [PubMed]
18. Burgers, J.S.; Voerman, G.E.; Grol, R.; Faber, M.J.; Schneider, E.C. Quality and coordination of care for patients
with multiple conditions: Results from an international survey of patient experience. Eval. Health Prof. 2010,
33, 343–364. [CrossRef] [PubMed]
19. Boyd, C.M.; Darer, J.; Boult, C.; Fried, L.P.; Boult, L.; Wu, A.W. Clinical practice guidelines and quality of
care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005,
294, 716–724. [CrossRef] [PubMed]
20. Mangin, D.; Heath, I.; Jamoulle, M. Beyond diagnosis: Rising to the multimorbidity challenge. BMJ 2012,
344, e3526. [CrossRef] [PubMed]
21. Starfield, B.; Shi, L.; Macinko, J. Contribution of primary care to health systems and health. Milbank Q. 2005,
83, 457–502. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2016, 13, 391 11 of 12
22. Agborsangaya, C.B.; Lau, D.; Lahtinen, M.; Cooke, T.; Johnson, J.A. Multimorbidity prevalence and patterns
across socioeconomic determinants: A cross-sectional survey. BMC Public Health 2012, 12, 201. [CrossRef]
[PubMed]
23. Schafer, I.; Hansen, H.; Schon, G.; Hofels, S.; Altiner, A.; Dahlhaus, A.; Gensichen, J.; Riedel-Heller, S.;
Weyerer, S.; Blank, W.A.; et al. The influence of age, sex and socio-economic status on multimorbidity
patterns in primary care. First results from the multicare cohort study. BMC Health Serv. Res. 2012, 12, 89.
[CrossRef] [PubMed]
24. McLean, G.; Gunn, J.; Wyke, S.; Guthrie, B.; Watt, G.C.; Blane, D.N.; Mercer, S.W. The influence of
socioeconomic deprivation on multimorbidity at different ages: A cross-sectional study. Br. J. Gen. Pract.
2014, 64, e440–e447. [CrossRef] [PubMed]
25. Violan, C.; Foguet-Boreu, Q.; Hermosilla-Pérez, E.; Valderas, J.M.; Bolíbar, B.; Fàbregas-Escurriola, M.;
Brugulat-Guiteras, P.; Muñoz-Pérez, M.Á. Comparison of the information provided by electronic health
records data and a population health survey to estimate prevalence of selected health conditions and
multimorbidity. BMC Public Health 2013, 13, 251. [CrossRef] [PubMed]
26. Prados-Torres, A.; Poblador-Plou, B.; Calderón-Larrañaga, A.; Gimeno-Feliu, L.A.; González-Rubio, F.;
Poncel-Falcó, A.; Sicras-Mainar, A.; Alcalá-Nalvaiz, J.T. Multimorbidity patterns in primary care: Interactions
among chronic diseases using factor analysis. PLoS ONE 2012, 7, e32190. [CrossRef] [PubMed]
27. Britt, H.C.; Harrison, C.M.; Millar, G.M.; Knox, S.A. Prevalence and patterns of multimorbidity in Australia.
Med. J. Aust. 2008, 189, 72–77. [PubMed]
28. Rizza, A.; Kaplan, V.; Senn, O.; Rosemann, T.; Bhend, H.; Tandjung, R. Age- and sex-related prevalence of
multimorbidity in primary care: The Swiss FIRE project. BMC Fam. Pract. 2012, 13, 113. [CrossRef] [PubMed]
29. Barford, A.; Dorling, D.; Davey Smith, G.; Shaw, M. Life expectancy: Women now on top everywhere. BMJ
2006, 332, 808. [CrossRef] [PubMed]
30. Borsch-Supan, A.; Brandt, M.; Hunkler, C.; Kneip, T.; Korbmacher, J.; Malter, F.; Schaan, B.; Stuck, S.; Zuber, S.;
SHARE Central Coordination Team. Data Resource Profile: The Survey of Health, Ageing and Retirement in
Europe (SHARE). Int. J. Epidemiol. 2013, 42, 992–1001. [CrossRef] [PubMed]
31. Elder, R.; Kirkpatrick, M.; Ramsay, W.; MacLeod, M.; Guthrie, B.; Sutton, M.; Watt, G. Measuring Quality in
Primary Medical Services Using Data from SPICE; NHS National Services Scotland: Edinburgh, UK, 2007.
32. QOF Frequently Asked Questions. July 2011. Available online: http://www.nhsemployers.org/~/media/
Employers/Documents/Primary%20care%20contracts/QOF/2011-12/UK%20QOF%20-%20Frequently%20
asked%20questions%20-%20July%202011.pdf (acessed on 12 December 2105).
33. Diederichs, C.; Berger, K.; Bartels, D.B. The measurement of multiple chronic diseases—A systematic review
on existing multimorbidity indices. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66, 301–311. [CrossRef] [PubMed]
34. Measuring Long-Term Conditions in Scotland. June 2008. Available online: http://www.isdscotland.org/
Health-Topics/Hospital-Care/Diagnoses/2008_08_14_LTC_full_report.pdf (accessed on 12 October 2105).
35. Van den Akker, M.; Buntinx, F.; Metsemakers, J.F.; Roos, S.; Knottnerus, J.A. Multimorbidity in
general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.
J. Clin. Epidemiol. 1998, 51, 367–375. [CrossRef]
36. St Sauver, J.L.; Boyd, C.M.; Grossardt, B.R.; Bobo, W.V.; Finney Rutten, L.J.; Roger, V.L.; Ebbert, J.O.;
Therneau, T.M.; Yawn, B.P.; Rocca, W.A. Risk of developing multimorbidity across all ages in an historical
cohort study: Differences by sex and ethnicity. BMJ Open 2015, 5, e006413. [CrossRef] [PubMed]
37. Garcia-Olmos, L.; Salvador, C.H.; Alberquilla, Á.; Lora, D.; Carmona, M.; García-Sagredo, P.; Pascual, M.;
Muñoz, A.; Monteagudo, J.L.; García-López, F. Comorbidity patterns in patients with chronic diseases in
general practice. PLoS ONE 2012, 7, e32141. [CrossRef] [PubMed]
38. Lochner, K.A.; Cox, C.S. Prevalence of multiple chronic conditions among Medicare beneficiaries,
United States, 2010. Prev. Chronic. Dis. 2013, 10, E61. [CrossRef] [PubMed]
39. Marengoni, A.; Winblad, B.; Karp, A.; Fratiglioni, L. Prevalence of chronic diseases and multimorbidity
among the elderly population in Sweden. Am. J. Public Health 2008, 98, 1198–1200. [CrossRef] [PubMed]
40. Van den Bussche, H.; Koller, D.; Kolonko, T.; Hansen, H.; Wegscheider, K.; Glaeske, G.; von Leitner, E.C.;
Schäfer, I.; Schön, G. Which chronic diseases and disease combinations are specific to multimorbidity in the
elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health 2011, 11, 101.
[CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2016, 13, 391 12 of 12
41. Wong, A.; Boshuizen, H.C.; Schellevis, F.G.; Kommer, G.J.; Polder, J.J. Longitudinal administrative data can
be used to examine multimorbidity, provided false discoveries are controlled for. J. Clin. Epidemiol. 2011, 64,
1109–1117. [CrossRef] [PubMed]
42. Spangenberg, L.; Forkmann, T.; Brähler, E.; Glaesmer, H. The association of depression and multimorbidity
in the elderly: Implications for the assessment of depression. Psychogeriatrics 2011, 11, 227–234. [CrossRef]
[PubMed]
43. Faravelli, C.; Alessandra Scarpato, M.; Castellini, G.; Lo Sauro, C. Gender differences in depression and
anxiety: The role of age. Psychiatry Res. 2013, 210, 1301–1303. [CrossRef] [PubMed]
44. Adams, A.; Buckingham, C.D.; Lindenmeyer, A.; McKinlay, J.B.; Link, C.; Marceau, L.; Arber, S. The influence
of patient and doctor sex on diagnosing coronary heart disease. Sociol. Health Illn. 2008, 30, 1–18. [CrossRef]
[PubMed]
45. Arber, S.; McKinlay, J.; Adams, A.; Marceau, L.; Link, C.; O’Donnell, A. Patient characteristics and inequalities
in doctors’ diagnostic and management strategies relating to CHD: A video-simulation experiment.
Soc. Sci. Med. 2006, 62, 103–115. [CrossRef] [PubMed]
46. Arber, S.; McKinlay, J.; Adams, A.; Marceau, L.; Link, C.; O’Donnell, A. Influence of patient characteristics
on doctors’ questioning and lifestyle advice for coronary heart disease: A UK/US video experiment. Br. J.
Gen. Pract. 2004, 54, 673–678. [PubMed]
47. Wang, Y.; Hunt, K.; Nazareth, I.; Freemantle, N.; Petersen, I. Do men consult less than women? An analysis
of routinely collected UK general practice data. BMJ Open 2013, 3, e003320. [CrossRef] [PubMed]
48. Lang, K.; Alexander, I.M.; Simon, J.; Sussman, M.; Lin, I.; Menzin, J.; Friedman, M.; Dutwin, D.;
Bushmakin, A.G.; Thrift-Perry, M.; et al. The impact of multimorbidity on quality of life among midlife
women: Findings from a u.s. Nationally representative survey. J. Womens Health (Larchmt) 2015, 24, 374–383.
[CrossRef] [PubMed]
49. Addis, M.E. Gender and depression in men. Clin. Psychol. Sci. Pract. 2008, 15, 153–168. [CrossRef]
50. Ahto, M.; Isoaho, R.; Puolijoki, H.; Vahlberg, T.; Kivelä, S.L. Stronger symptoms of depression predict high
coronary heart disease mortality in older men and women. Int. J. Geriatr. Psychiatry 2007, 22, 757–763.
[CrossRef] [PubMed]
51. Bijl, R.V.; De Graaf, R.; Ravelli, A.; Smit, F.; Vollebergh, W.A.; Netherlands Mental Health Survey
and Incidence Study. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the
general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).
Soc. Psychiatry Psychiatr. Epidemiol. 2002, 37, 372–379. [CrossRef] [PubMed]
52. Batty, G.D.; Hunt, K.; Emslie, C.; Lewars, H.; Gale, C.R. Alcohol problems and all-cause mortality in men and
women: Predictive capacity of a clinical screening tool in a 21-year follow-up of a large, UK-wide, general
population-based survey. J. Psychosom. Res. 2009, 66, 317–321. [CrossRef] [PubMed]
53. Wilsnack, R.W.; Vogeltanz, N.D.; Wilsnack, S.C.; Harris, T.R.; Ahlström, S.; Bondy, S.; Csémy, L.; Ferrence, R.;
Ferris, J.; Fleming, J.; et al. Gender differences in alcohol consumption and adverse drinking consequences:
Cross-cultural patterns. Addiction 2000, 95, 251–265. [CrossRef] [PubMed]
54. Azorin, J.M.; Belzeaux, R.; Fakra, E.; Kaladjian, A.; Hantouche, E.; Lancrenon, S.; Adida, M. Gender
differences in a cohort of major depressive patients: Further evidence for the male depression syndrome
hypothesis. J. Affect. Disord. 2014, 167, 85–92. [CrossRef] [PubMed]
55. Schuch, J.J.; Roest, A.M.; Nolen, W.A.; Penninx, B.W.; de Jonge, P. Gender differences in major depressive
disorder: Results from the Netherlands study of depression and anxiety. J. Affect. Disord. 2014, 156, 156–163.
[CrossRef] [PubMed]
56. Plochg, T.; Klazinga, N.S.; Starfield, B. Transforming medical professionalism to fit changing health needs.
BMC Med. 2009, 7, 64. [CrossRef] [PubMed]
57. Stange, K.C. The generalist approach. Ann. Fam. Med. 2009, 7, 198–203. [CrossRef] [PubMed]
58. WHO. Gender Disparities in Mental Health. Available online: http://www.who.int/mental_health/
media/en/242.pdf (accessed on 12 October 2015).
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons by Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
